Anbieter: Basi6 International, Irving, TX, USA
Zustand: Brand New. New.SoftCover International edition. Different ISBN and Cover image but contents are same as US edition.Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Anbieter: ThriftBooks-Dallas, Dallas, TX, USA
Hardcover. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Anbieter: PBShop.store US, Wood Dale, IL, USA
PAP. Zustand: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 13,85
Anzahl: Mehr als 20 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Anbieter: SHIMEDIA, Brooklyn, NY, USA
Zustand: New. Satisfaction Guaranteed or your money back.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 243,63
Anzahl: 9 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 265,26
Anzahl: 9 verfügbar
In den WarenkorbZustand: New.
Anbieter: moluna, Greven, Deutschland
EUR 239,03
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Mark Rogge, David R. TaftPreclinical Drug Development, Second Edition discusses the broad and complicated realm of preclinical drug development. Topics range from assessment of pharmacology and toxicology to industry trends and regul.
Anbieter: ECOSPHERE, Champs sur marne, Frankreich
Couverture rigide. Zustand: Neuf. 2ème Édition.
Anbieter: Buchpark, Trebbin, Deutschland
Zustand: Gut. Zustand: Gut | Sprache: Deutsch | Produktart: Bücher | Keine Beschreibung verfügbar.
Anbieter: CitiRetail, Stevenage, Vereinigtes Königreich
EUR 17,23
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: new. Paperback. Phoenix Rewritten: The Rise of Policy-Driven SecurityBy Mark O. RoggeA single overlooked account. A catastrophic data breach. A race to rebuild trust before the entire company collapses.When a late-night phone call jolts CISO Lauren Reyes from her sleep, she's thrust into the eye of a storm: a devastating cyberattack has compromised millions of patient records at Zenith, one of the nation's largest healthcare providers. But what begins as a technical investigation quickly spirals into a chilling realization-the true threat isn't outside the firewall. It's embedded deep within the architecture of the organization itself.In this gripping corporate techno-thriller, author Mark O. Rogge weaves a suspense-filled narrative that explores the modern crisis of digital trust. As Lauren and her team uncover layer upon layer of neglected service accounts, ghost permissions, and hidden architectural flaws, they discover a concept that could either save or doom the company: Policy Debt.Enter Elias Tran, a mysterious expert with a blueprint for transformation-leveraging Open Policy Agent (OPA) and a revolutionary concept known as policy-as-code. But rebuilding trust means more than just deploying new tools; it means dismantling decades of cultural inertia, breaking down silos, and reimagining how access is defined across every corner of the enterprise.Phoenix Rewritten is a must-read for CISOs, DevSecOps leaders, and technology executives navigating the high-stakes world of security, compliance, and enterprise transformation. Part business thriller, part field manual, it's a visceral story of leadership, failure, and the rising call for policy-driven security in an age where digital trust is everything. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 259,90
Anzahl: 3 verfügbar
In den WarenkorbZustand: New. pp. 536 Illus. This item is printed on demand.
Sprache: Englisch
Verlag: Taylor & Francis, CRC Press, 2009
ISBN 10: 1420084720 ISBN 13: 9781420084726
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Preclinical Drug Development, Second Edition discusses the broad and complicated realm of preclinical drug development. Topics range from assessment of pharmacology and toxicology to industry trends and regulatory expectations to requirements that support clinical trials. Highlights of the Second Edition include: PharmacokineticsModeling and simulationFormulation and routes of administrationToxicity evaluationsThe assessment of drug absorption and metabolismInterspecies scaling Lead molecule selection and optimization via profilingScreening using in silico and in vitro toxicity evaluations The book also includes case studies on preclinical pharmacokinetic-pharmacodynamic modeling and simulation in drug development, a review of ICH preclinical guidelines, and experimental methods used to study membrane drug transport and metabolism. This guide is a fundamental resource for medicinal chemists, biologists, and other specialists in the drug development sciences. 380 pp. Englisch.
Sprache: Englisch
Verlag: Taylor & Francis, CRC Press, 2009
ISBN 10: 1420084720 ISBN 13: 9781420084726
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Preclinical Drug Development, Second Edition discusses the broad and complicated realm of preclinical drug development. Topics range from assessment of pharmacology and toxicology to industry trends and regulatory expectations to requirements that support clinical trials. Highlights of the Second Edition include: PharmacokineticsModeling and simulationFormulation and routes of administrationToxicity evaluationsThe assessment of drug absorption and metabolismInterspecies scaling Lead molecule selection and optimization via profilingScreening using in silico and in vitro toxicity evaluations The book also includes case studies on preclinical pharmacokinetic-pharmacodynamic modeling and simulation in drug development, a review of ICH preclinical guidelines, and experimental methods used to study membrane drug transport and metabolism. This guide is a fundamental resource for medicinal chemists, biologists, and other specialists in the drug development sciences.